Latest Insider Transactions at Merrimack Pharmaceuticals Inc (MACK)
This section provides a real-time view of insider transactions for Merrimack Pharmaceuticals Inc (MACK). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of MERRIMACK PHARMACEUTICALS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of MERRIMACK PHARMACEUTICALS INC's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Aug 13
2020
|
Eric Andersen |
BUY
Open market or private purchase
|
Indirect |
609
+0.07%
|
$1,827
$3.5 P/Share
|
Aug 12
2020
|
Noah G. Levy Director |
BUY
Open market or private purchase
|
Indirect |
2,000
+0.14%
|
$6,000
$3.49 P/Share
|
Aug 12
2020
|
Eric Andersen |
BUY
Open market or private purchase
|
Indirect |
2,000
+0.82%
|
$6,000
$3.49 P/Share
|
Aug 11
2020
|
Noah G. Levy Director |
BUY
Open market or private purchase
|
Indirect |
14,042
+1.0%
|
$42,126
$3.45 P/Share
|
Aug 11
2020
|
Eric Andersen |
BUY
Open market or private purchase
|
Indirect |
14,030
+5.5%
|
$42,090
$3.45 P/Share
|
Jul 22
2020
|
Noah G. Levy Director |
BUY
Open market or private purchase
|
Indirect |
177,274
+6.23%
|
$531,822
$3.12 P/Share
|
Jul 22
2020
|
Eric Andersen |
BUY
Open market or private purchase
|
Indirect |
177,274
+8.97%
|
$531,822
$3.12 P/Share
|
Apr 21
2020
|
Eric Andersen |
BUY
Open market or private purchase
|
Indirect |
1,424
+0.21%
|
$4,272
$3.25 P/Share
|
Apr 21
2020
|
Noah G. Levy Director |
BUY
Open market or private purchase
|
Indirect |
1,424
+0.12%
|
$4,272
$3.25 P/Share
|
Apr 20
2020
|
Eric Andersen |
BUY
Open market or private purchase
|
Indirect |
2,325
+0.34%
|
$6,975
$3.25 P/Share
|
Apr 20
2020
|
Noah G. Levy Director |
BUY
Open market or private purchase
|
Indirect |
2,325
+0.19%
|
$6,975
$3.25 P/Share
|
Apr 07
2020
|
Noah G. Levy Director |
BUY
Open market or private purchase
|
Indirect |
5,899
+0.49%
|
$17,697
$3.03 P/Share
|
Apr 07
2020
|
Eric Andersen |
BUY
Open market or private purchase
|
Indirect |
5,899
+0.85%
|
$17,697
$3.03 P/Share
|
Apr 06
2020
|
Noah G. Levy Director |
BUY
Open market or private purchase
|
Indirect |
6,042
+0.5%
|
$18,126
$3.0 P/Share
|
Apr 06
2020
|
Eric Andersen |
BUY
Open market or private purchase
|
Indirect |
6,043
+0.88%
|
$18,129
$3.0 P/Share
|
Apr 03
2020
|
Noah G. Levy Director |
BUY
Open market or private purchase
|
Indirect |
10,750
+0.9%
|
$21,500
$2.59 P/Share
|
Apr 03
2020
|
Eric Andersen |
BUY
Open market or private purchase
|
Indirect |
10,750
+1.56%
|
$21,500
$2.6 P/Share
|
Apr 17
2019
|
22 Nw, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
16,200
+1.29%
|
$97,200
$6.0 P/Share
|
Apr 16
2019
|
22 Nw, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
20,450
+1.64%
|
$102,250
$5.95 P/Share
|
Apr 15
2019
|
22 Nw, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
30,110
+2.44%
|
$150,550
$5.73 P/Share
|
Apr 08
2019
|
22 Nw, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
32,873
+2.72%
|
$164,365
$5.81 P/Share
|
Apr 05
2019
|
22 Nw, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
50,000
+4.19%
|
$300,000
$6.12 P/Share
|